Related Experiment Videos
Peritoneal healing with adhesion formation: current comment
F H Watkins1, D B Drake, L E Holmdahl
1Department of Plastic Surgery, University of Virginia School of Medicine, Charlottesville 22908, USA.
Insights
Intra-abdominal adhesions can cause serious complications like bowel obstruction and infertility. New drugs and synthetic barriers are now available to prevent adhesion formation, improving surgical outcomes.
Area of Science:
- Surgical pathology
- Biomaterials science
- Gastroenterology
Background:
- Intra-abdominal adhesions are fibrous bands connecting abdominal organs, leading to complications such as intestinal obstruction, infertility, and pelvic pain.
- Understanding peritoneal healing and wound repair has advanced therapeutic strategies to mitigate adhesion development.
Purpose of the Study:
- To review current therapeutic techniques for preventing intra-abdominal adhesion formation.
- To highlight novel pharmacological and biomaterial interventions.
Main Methods:
- Review of recent advancements in adhesion prevention strategies.
- Identification of new drugs and synthetic barrier materials.
Main Results:
- Dextran 70 and poloxamer 407 are new drugs developed to inhibit adhesion formation.
- Oxidized regenerated cellulose, hyaluronate membrane, and polytetrafluoroethylene serve as synthetic barriers to prevent adhesions.
Conclusions:
- Emerging pharmacological agents and biomaterials offer promising solutions for preventing intra-abdominal adhesions.
- These advancements aim to reduce the incidence of adhesion-related clinical complications.
Abstract:
Intra-abdominal adhesions are fibrotic structures, which lie in the form of a string or attachment between the abdominal organs and connect these together. They are responsible for serious clinical complications that include intestinal obstruction, infertility, and pelvic pain. During the last century, surgeons' comprehensive understanding of the biology of peritoneal healing and wound repair has allowed them to identify a variety of new therapeutic techniques that limit the development of adhesion formation. New drugs, dextran 70 and poloxamer 407, have been developed to prevent adhesion formation. In addition, three new biomaterials (oxidized regenerated cellulose, hyaluronate membrane, and polytetrafluoroethylene) are synthetic barriers being used to prevent adhesions.